Project Description:
Title: FALCON Study: An interventional, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose, adaptive study of the efficacy of KL 1333 in patients with primary mitochondrial disease
Role: Site PI
Funding: Abliva AB
2023-present
Summary: This study is an interventional, randomized, double-blind, parallel-group, placebo-controlled study to assess the efficacy of KL 1333 in adult patients with primary mitochondrial disease.
Core Function(s):
Training Trainees, Performing Direct and/or Demonstration Services, Continuing Education/Community Training, Other Direct/Model Services
Area of Emphasis
Quality Assurance, Education & Early Intervention
Target Audience:
Adults with Disabilities
Unserved or Under-served Populations:
Geographic Area - Other, Other
Primary Target Audience Geographic Descriptor:
National
COVID-19 Related Data:
N/A